Active Ingredient(s): Sapropterin Dihydrochloride
FDA Approved: * December 13, 2007
Pharm Company: * BIOMARIN PHARM
Category: Enzymes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Kuvan Overview

Tetrahydrobiopterin (BH4, THB), also known as sapropterin (INN),[2][3] is a cofactor of the three aromatic amino acid hydroxylase enzymes,[4] used in the degradation of amino acid phenylalanine and in the biosynthesis of the neurotransmitters serotonin (5-hydroxytryptamine, 5-HT), melatonin, dopamine, norepinephrine (noradrenaline), epinephrine (adrenaline), and is a cofactor for the production of nitric oxide (NO) by the nitric oxide syntheses....

Read more Kuvan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tetrahydrobiopterin

Recent Kuvan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sapropterin Dihydrochloride
  • Powder: 100mg, 100mg/packet, 500mg/packet
  • Powder For Oral Solution: 100mg/packet
  • Tablet: 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Kuvan: (3 results)

Sorted by National Drug Code
  • 68135-300 Kuvan 100 mg Oral Tablet for 4-8 Oz Oral Solution by Biomarin Pharmaceutical Inc.
  • 68135-301 Kuvan 100 mg/1 Oral Powder, for Solution by Biomarin Pharmaceutical Inc.
  • 68135-482 Kuvan 500 mg Oral Powder, for Solution by Biomarin Pharmaceutical Inc.

Other drugs which contain Sapropterin Dihydrochloride or a similar ingredient: (1 result)